(Q50792115)

English

Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration.

scientific article published on 10 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

author name string

S Davis

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

J Brazier

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

publication date

10 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

21

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

12

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

1455-1463

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

https://scigraph.springernature.com/pub.10.1038/sj.eye.6702636

0 references

Age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Adult vitelliform macular degeneration: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Utility values and age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

An introduction to Markov modelling for economic evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

What is the cost of blindness?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Handling uncertainty in cost-effectiveness models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

The Impact of Age-Related Macular Degeneration on Health Status Utility Values

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

21 January 2018

Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Two eyes are better than one: binocular enhancement in the contrast domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Binocular contrast inhibition in subjects with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Binocular vision in older people with adventitious visual impairment: sometimes one eye is better than two

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702636

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.EYE.6702636

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17086167

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50792115&oldid=1465676578"